Russell Investments Group Ltd. decreased its stake in shares of DENTSPLY SIRONA Inc. (NASDAQ:XRAY) by 4.6% during the second quarter, according to its most recent 13F filing with the Securities and Exchange Commission. The firm owned 151,441 shares of the medical instruments supplier’s stock after selling 7,376 shares during the period. Russell Investments Group Ltd.’s holdings in DENTSPLY SIRONA were worth $9,823,000 as of its most recent filing with the SEC.

Several other hedge funds have also recently made changes to their positions in XRAY. Harvey Investment Co. LLC increased its stake in shares of DENTSPLY SIRONA by 0.9% in the second quarter. Harvey Investment Co. LLC now owns 210,027 shares of the medical instruments supplier’s stock valued at $13,618,000 after buying an additional 1,856 shares during the last quarter. Gilbert & Cook Inc. purchased a new stake in shares of DENTSPLY SIRONA during the second quarter valued at approximately $225,000. Quantitative Systematic Strategies LLC purchased a new stake in shares of DENTSPLY SIRONA during the second quarter valued at approximately $390,000. Farmers & Merchants Investments Inc. increased its stake in shares of DENTSPLY SIRONA by 2.1% in the second quarter. Farmers & Merchants Investments Inc. now owns 96,521 shares of the medical instruments supplier’s stock valued at $6,258,000 after buying an additional 2,000 shares during the last quarter. Finally, BB&T Corp increased its stake in shares of DENTSPLY SIRONA by 32.2% in the second quarter. BB&T Corp now owns 14,961 shares of the medical instruments supplier’s stock valued at $970,000 after buying an additional 3,642 shares during the last quarter. Hedge funds and other institutional investors own 95.13% of the company’s stock.

Shares of DENTSPLY SIRONA Inc. (NASDAQ:XRAY) traded down 1.30% during trading on Wednesday, hitting $53.06. 1,120,365 shares of the company’s stock were exchanged. DENTSPLY SIRONA Inc. has a 12-month low of $52.73 and a 12-month high of $65.68. The company’s market cap is $12.18 billion. The company has a 50-day moving average of $62.34 and a 200-day moving average of $62.34.

DENTSPLY SIRONA (NASDAQ:XRAY) last posted its quarterly earnings data on Wednesday, August 9th. The medical instruments supplier reported $0.65 earnings per share for the quarter, hitting the Zacks’ consensus estimate of $0.65. The company had revenue of $992.70 million during the quarter, compared to analysts’ expectations of $1 billion. DENTSPLY SIRONA had a negative net margin of 20.57% and a positive return on equity of 7.24%. The firm’s revenue for the quarter was down 2.9% on a year-over-year basis. During the same period in the prior year, the business posted $0.76 earnings per share. On average, equities analysts expect that DENTSPLY SIRONA Inc. will post $2.72 earnings per share for the current fiscal year.

The firm also recently announced a quarterly dividend, which will be paid on Friday, October 13th. Stockholders of record on Friday, September 29th will be given a $0.0875 dividend. This represents a $0.35 dividend on an annualized basis and a dividend yield of 0.65%. The ex-dividend date of this dividend is Thursday, September 28th. DENTSPLY SIRONA’s dividend payout ratio (DPR) is -10.09%.

COPYRIGHT VIOLATION WARNING: This news story was originally reported by Watch List News and is owned by of Watch List News. If you are accessing this news story on another website, it was copied illegally and republished in violation of US and international trademark and copyright legislation. The original version of this news story can be accessed at https://www.watchlistnews.com/dentsply-sirona-inc-xray-position-decreased-by-russell-investments-group-ltd/1496094.html.

Several brokerages have recently commented on XRAY. BidaskClub downgraded shares of DENTSPLY SIRONA from a “sell” rating to a “strong sell” rating in a research report on Wednesday. Zacks Investment Research downgraded shares of DENTSPLY SIRONA from a “hold” rating to a “sell” rating in a research report on Monday. HC Wainwright restated a “buy” rating and set a $68.00 price objective (down from $74.00) on shares of DENTSPLY SIRONA in a research report on Monday. TheStreet downgraded shares of DENTSPLY SIRONA from a “b” rating to a “c+” rating in a research report on Wednesday, August 9th. Finally, UBS AG restated a “neutral” rating and set a $59.00 price objective (down from $62.00) on shares of DENTSPLY SIRONA in a research report on Thursday, August 10th. Three investment analysts have rated the stock with a sell rating, three have issued a hold rating and eight have issued a buy rating to the stock. The company currently has an average rating of “Hold” and an average target price of $66.25.

DENTSPLY SIRONA Company Profile

DENTSPLY SIRONA Inc is a manufacturer of professional dental products and technologies. The Company develops, manufactures, and markets solutions offering, including dental and oral health products, as well as other consumable medical devices. It operates through two segments: Dental and Healthcare Consumables, and Technologies.

Want to see what other hedge funds are holding XRAY? Visit HoldingsChannel.com to get the latest 13F filings and insider trades for DENTSPLY SIRONA Inc. (NASDAQ:XRAY).

Institutional Ownership by Quarter for DENTSPLY SIRONA (NASDAQ:XRAY)

Receive News & Ratings for DENTSPLY SIRONA Inc. Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for DENTSPLY SIRONA Inc. and related companies with Analyst Ratings Network's FREE daily email newsletter.